| Literature DB >> 31291944 |
Neelam Thakur1, Prasenjit Manna2, Joydeep Das3.
Abstract
BACKGROUND: Nanoceria has recently received much attention, because of its widespread biomedical applications, including antibacterial, antioxidant and anticancer activity, drug/gene delivery systems, anti-diabetic property, and tissue engineering. MAIN BODY: Nanoceria exhibits excellent antibacterial activity against both Gram-positive and Gram-negative bacteria via the generation of reactive oxygen species (ROS). In healthy cells, it acts as an antioxidant by scavenging ROS (at physiological pH). Thus, it protects them, while in cancer cells (under low pH environment) it acts as pro-oxidant by generating ROS and kills them. Nanoceria has also been effectively used as a carrier for targeted drug and gene delivery in vitro and in vivo models. Besides, nanoceria can also act as an antidiabetic agent and confer protection towards diabetes-associated organ pathophysiology via decreasing the ROS level in diabetic subjects. Nanoceria also possesses excellent potential in the field of tissue engineering. In this review, firstly, we have discussed the different methods used for the synthesis of nanoceria as these are very important to control the size, shape and Ce3+/Ce4+ ratio of the particles upon which the physical, chemical, and biological properties depend. Secondly, we have extensively reviewed the different biomedical applications of nanoceria with probable mechanisms based on the literature reports.Entities:
Keywords: Anti-cancer activity; Anti-diabetic effect; Antibacterial activity; Antioxidant activity; Drug/gene delivery; Nanoceria
Mesh:
Substances:
Year: 2019 PMID: 31291944 PMCID: PMC6617741 DOI: 10.1186/s12951-019-0516-9
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 10.435
Fig. 1Different methods for the synthesis of nanoceria. a Precipitation method, b hydrothermal method, c green synthesis, d microwave-assisted method, e micro-emulsion method, f oxidation method and g sonochemical method
Synthesis of nanoceria by precipitation method
| S. no | Precursors | Medium | Method | References |
|---|---|---|---|---|
| 1. | Cerium chloride heptahydrate, CTAB surfactant, and ammonia solution | Water | Precipitation | [ |
| 2. | Ammonium cerium nitrate and urea | Water | Homogeneous precipitation | [ |
| 3. | Cerium nitrate hexahydrate, ammonia solution, hydrogen peroxide, and hexamethylenetetramine | Water | Precipitation | [ |
| 4. | Hydrated Cerium acetate, sodium bis(2-ethylhexyl) sulfosuccinate, ammonia solution | Water and ethanol | Solution phase method | [ |
| 5. | Cerium nitrate hexahydrate and sodium hydroxide | Water | Precipitation | [ |
| 6. | Cerium nitrate hexahydrate, ammonium hydroxide, acetone and tween 80 | Acetone-water mixed solvent system | Surfactant-mediated precipitation method | [ |
| 7. | Cerium nitrate hexahydrate, dextran and ammonia solution | Water | Precipitation method | [ |
| 8. | Cerium nitrate, europium nitrate and ammonium hydroxide s | Water | Co precipitation | [ |
| 9. | Cerium nitrate hexahydrate, ammonia and ammonium bicarbonate | Water | Precipitation method | [ |
| 10. | Cerium nitrate hexahydrate, sodium hydroxide, and polyethylene glycol | Water | Chemical precipitation | [ |
| 11. | Cerium nitrate hexahydrate and aqueous ammonia | Water | Homogeneous precipitation | [ |
| 12. | Cerium chloride heptahydrate, CTAB surfactant, and ammonia solution | Water | Precipitation | [ |
| 13. | Cerium nitrate hexahydrate and aqueous ammonia | Water | Precipitation | [ |
| 14. | Cerium nitrate hexahydrate, EDTA and ammonium carbonate | Water | Chemical precipitation | [ |
| 15. | Cerium nitrate hexahydrate and potassium carbonate | Water | Co-precipitation method | [ |
| 16. | Cerium nitrate hexahydrate, polyacrylic acid, and ammonium hydroxide | Water | Precipitation method | [ |
| 17. | Cerium nitrate hexahydrate and ammonium hydroxide | Water | Precipitation method | [ |
| 18. | Cerium nitrate hexahydrate, xanthan gum, and ammonia solution | Water | Co-precipitation method | [ |
Synthesis of nanoceria by hydrothermal method
| S. no | Precursors | Medium | Method | References |
|---|---|---|---|---|
| 1. | Cerium chloride hexahydrate, citric acid, and ammonia water | Water | Hydrothermal crystallization | [ |
| 2. | Cerium nitrate and sodium hydroxide | Water | Hydrothermal method | [ |
| 3. | Cerium nitrate hexahydrate and sodium hydroxide | Water | Hydrothermal method | [ |
| 4. | Cerium nitrate hexahydrate and ammonium hydroxide | Water | Hydrothermal method | [ |
| 5. | Cerium nitrate hexahydrate and Polyvinyl pyrrolidone | Water | Surfactant-assisted hydrothermal method | [ |
| 6. | Ceric ammonium nitrate and ammonium carbonate | Water | Hydrothermal method | [ |
| 7. | Cerium chloride and ammonium hydroxide | Water | Hydrothermal method | [ |
| 8. | Cerium nitrate and sodium hydroxide | Water | Hydrothermal method | [ |
| 9. | Cerium nitrate hexahydrate and sodium hydroxide | Water | Hydrothermal method | [ |
Synthesis of nanoceria by green/bio-directed synthesis
| S. no | Precursors | Medium | Method | References |
|---|---|---|---|---|
| 1. | Cerium(III) acetate hydrate and egg white | Water | Bio-directed synthesis | [ |
| 2. | Cerium chloride heptahydrate and | Water | Green approach | [ |
| 3. | Cerium nitrate hexahydrate, gum tragacanth from | Water | Gum mediated synthesis | [ |
| 4. | Cerium chloride heptahydrate and | Water | Mycosynthesis | [ |
| 5. | Cerium nitrate hexahydrate and aloe vera leaf extract | Water | Green method | [ |
| 6. | Cerium nitrate hexahydrate, starch, and ammonium hydroxide solution | Water | Green synthesis | [ |
| 7. | Cerium nitrate hexahydrate and honey | Water | Green synthesis | [ |
| 8. | Water | Green synthesis | [ | |
| 9. | Cerium nitrate hexahydrate and fresh egg white | Water | Bio-directed synthesis | [ |
| 10. | Cerium nitrate hexahydrate and | Water | Green synthesis | [ |
| 11. | Cerium nitrate hexahydrate and agarose | Water | Bio-organic polymer-based synthesis | [ |
| 12. | Cerium nitrate hexahydrate and | Water | Green synthesis | [ |
| 13. | Cerium nitrate solution, pectin and ammonia solution | Water | Bio polymer mediated synthesis | [ |
Synthesis of nanoceria by oxidation method
| S. no | Precursors | Medium | Method | References |
|---|---|---|---|---|
| 1. | Cerium nitrate hexahydrate, hydrogen peroxide, and ammonia solution | Water | Hydrothermal oxidation method | [ |
| 2. | Cerium nitrate hexahydrate, ammonia solution, and hydrogen peroxide | Water | Oxidation method | [ |
| 3. | Cerium sulfate, sodium hydroxide, and hydrogen peroxide | Water | Sonochemical oxidation | [ |
| 4. | Cerium nitrate hexahydrate and hydrogen peroxide | Water | Oxidation | [ |
| 5. | Cerium nitrate, polyethylene glycol, and hydrogen peroxide | 20% polyethylene glycol solution | Oxidation | [ |
| 6. | Cerium nitrate hexahydrate, dextran and ammonium hydroxide | Water | Oxidation | [ |
| 7. | Cerium nitrate hexahydrate, polyacrylic acid, and ammonium hydroxide | Water | Oxidation | [ |
| 8. | Cerium (III) acetate hydrate and hydrogen peroxide | Water | Precipitation method | [ |
| 9. | Cerium nitrate hexahydrate and hydrogen peroxide | Polyethylene glycol | Oxidation | [ |
| 10. | Cerium nitrate hexahydrate, hydrogen peroxide, and ammonium hydroxide | Dextran | Oxidation | [ |
Synthesis of nanoceria by sonochemical method
| S. no | Precursors | Medium | Method | References |
|---|---|---|---|---|
| 1. | Cerium nitrate and azodicarbonamide | Water | Sonochemical synthesis | [ |
| 2. | Ammonium cerium nitrate, hexamethylenetetramine, and polyethylene glycol | Water | Sonochemical method | [ |
| 3. | Cerium nitrate hexahydrate, tetra ethylene glycol, and ammonium hydroxide | Water | Sonochemical method | [ |
| 4. | Cerium nitrate hexahydrate, CTAB surfactant, and ammonia solution | Water | Ultrasonication | [ |
| 5. | Cerium nitrate hexahydrate and aqueous ammonia solution | Water | Sonochemical hydrolysis method | [ |
Synthesis of nanoceria by microwave-assisted method
| S. no | Precursors | Medium | Method | References |
|---|---|---|---|---|
| 1. | Ammonium cerium nitrate, hexamethylenetetramine, and polyethylene glycol | Water | Microwave-assisted heating | [ |
| 2. | Ammonium cerium nitrate and sodium hydroxide | Water | Microwave-assisted hydrothermal method | [ |
| 3. | Cerium nitrate hexahydrate, ethylene glycol, oleic acid, and tert-butylamine | Water | Microwave-assisted method | [ |
| 4. | Cerium nitrate hexahydrate, propylene glycol, and ammonia | Water | Microwave technique | [ |
| 5. | Ceric ammonium nitrate and sodium hydroxide | Water | Microwave-mediated synthesis | [ |
Synthesis of nanoceria by combustion method
| S. no | Precursors | Medium | Method | References |
|---|---|---|---|---|
| 1. | Cerium nitrate hexahydrate, europium nitrate, and urea | Water | Solution combustion synthesis | [ |
| 2. | Cerium nitrate, rare earth nitrate, and anhydrous citric acid | Water | Combustion method | [ |
| 3. | Cerium nitrate hexahydrate, Sm(NO3)3, urea and PVA | Water | Combustion method | [ |
| 4. | Ceric ammonium nitrate and EDTA disodium salt | Water | Solution combustion method | [ |
Synthesis of nanoceria by a microemulsion method
| S. no | Precursors | Medium | Method | References |
|---|---|---|---|---|
| 1. | Cerium nitrate hexahydrate, ammonium hydroxide and bis (2-ethylhexyl)sulphosuccinate | Toluene and water | Microemulsion method | [ |
| 2. | Cerium nitrate hexahydrate sodium hydroxide and cetyl trimethyl ammonium bromide | Water and | Reverse micellar method or water in oil microemulsion | [ |
| 3. | Cerium nitrate hexahydrate, ammonium hydroxide, polyvinylpyrrolidone and butanol | Water and | Microemulsion method | [ |
| 4. | Cerium(III) 2-ethylhexanoate, ammonia, and hexaethylene glycol isodecyl ether | Water and hexane | Oil in water microemulsion | [ |
Synthesis of nanoceria by Sol–gel method
| S. no | Precursors | Medium | Method | References |
|---|---|---|---|---|
| 1. | Cerium nitrate hexahydrate and oleic acid | Tri- | Nonhydrolytic sol–gel method | [ |
| 2. | Cerium nitrate hexahydrate and europium nitrate pentahydrate and citric acid monohydrate | Water and polyethylene glycol | Sol–gel method | [ |
| 3. | Cerium chloride heptahydrate and aqueous ammonia solution | Water and methanol | Sol–gel method | [ |
Synthesis of nanoceria by other methods
| S. no | Precursors | Medium | Method | References |
|---|---|---|---|---|
| 1. | Cerium acetate hydrate, oleyamine, oleic acid, and NaOH | Hexadecane | Nonhydrolytic solvent method | [ |
| 2. | Cerium nitrate hexahydrate and ethylene diamine | Ethylenediamine and water | Direct room temperature and solvothermal method | [ |
| 3. | Cerium nitrate hexahydrate and 6-aminohexanoic acid (AHA) | Water | Aqueous phase synthesis | [ |
| 4. | Cerium carbonate hydrate, and Molten KOH–NaOH mixture | Nil | Partial oxidation method | [ |
| 5. | Cerium nitrate | Water | Solution plasma process | [ |
Fig. 2Mechanism of antibacterial activity of nanoceria. a Direct contact, showing the direct interaction of Cerium oxide nanoparticles (CNPs) with bacterial cell wall that damage the cell wall and gets penetrated inside the cell and generates reactive oxygen species (ROS) which affects DNA, ribosomes, and proteins. b Indirect contact, showing the interaction of CNPs with the bacterial environment outside the cell and generates ROS that further enters into the cell by damaging the cell wall and affects DNA, ribosomes, and proteins. Both mechanisms ultimately lead to cell death
Antibacterial activity
| S. no | Particle size/morphology | Type of bacteria | Conc. | Observation | References |
|---|---|---|---|---|---|
| 1. | 7 nm/ellipsoidal |
| 0 to 730 mg/L | A large amount of CNPs was adsorbed on the | [ |
| 2. | 140 nm |
| 10 mg/mL | A drastic decrease in the concentration of | [ |
| 3. | 7 nm 25 nm/truncated octahedral, rhombus or irregular |
| 10, 100, and 200 mg/L | Direct contact of CNPs with the surface of | [ |
| 4. | 8–10 nm |
| 4.3 ppm | Dextran-coated CeO2 are non-toxic or exert mild anti-bacterial activity to | [ |
| 5. | 25-50 nm |
| 5.0 g/L | Under UV irradiation (2 h), CeO2 inhibited the growth of | [ |
| 6. | 100 nm/octahedral or truncated octahedral |
| 0.075, 0.125, 0.15, 0.175 0.5, 1.0, 1.5, 3.0 and 30 mg/mL | The interaction of nanoceria with non ionic surfactants enhanced their antibacterial activity against | [ |
| 7. | 25–30 nm/elliptically spherical | – | Nanoceria inhibited bacterial growth by more than 90% | [ | |
| 8. | 10–20 nm | 50 mg/mL, 250 mg/mL and 500 mg/mL | Nanoceria disrupted cell membranes of bacteria which led to the irreversible damage to the cell envelope which further results in cell death | [ | |
| 9. | 25 nm | 16 µg/mL, 8 µg/mL and 4 µg/mL | Bacterial toxicity is due to the direct interaction between the nanoceria with bacteria which further results in cell death | [ | |
| 10. | 5 nm |
| 0.22 mg/mL | Nanoceria seems to be very effective against | [ |
| 11. | 5 nm/spherical | 10, 50 and 100 mg | Nanoceria showed strong antibacterial activity | [ | |
| 12. | 42 nm/spherical | 500, 750 and 1000 µg/50 mL | With the increase in the concentration of nanoceria, zone of inhibition also increases in the case of | [ | |
| 13. | 11 nm/spherical | 1, 3 and 5 mg/disc | Nanoceria exhibited a good antibacterial activity and also showed the inhibition of respective bacterial biofilm formation | [ | |
| 14. | 27 nm/spherical | 200 µg | Interaction with nanoparticles causes bacterial cell death due to the generation of reactive oxygen species | [ | |
| 15. | 3.5–6.5 nm |
| – | Nanoceria significantly inhibited the growth of | [ |
| 16. | 3–4 nm/spherical | 250 μg/mL and 500 µg/mL | Nanoceria possess perfect antibacterial activity against the bacteria at basic pH values as compare to acidic pH values | [ | |
| 17. | 40–100 nm/spherical, Cubical and Circular |
| 20 µl of 25%, 50% and 100% conc. | Nanoceria was very effective against the test organisms and also showed a zone of inhibition for Gram-negative bacteria | [ |
Fig. 3Mechanism of the antioxidant activity of nanoceria. a Effect of free radical inducers on healthy cells in the absence of Cerium oxide nanoparticles (CNPs), which ultimately leads to cell death. b Effect of free radical inducers on healthy cells in the presence of CNPs, which restores the reasonable condition of the cell
Fig. 4Mechanism of pro-oxidant and antioxidant effect of nanoceria. Cerium oxide nanoparticles (CNPs) showing pro-oxidant effect in the cancer cell by entering into the cell through receptor-mediated endocytosis and get released into the cytoplasm from the endosome. This acidic intracellular pH favors the SOD mimetic activity of CNPs, which reduce superoxide into H2O2 but inhibits its CAT mimetic activity resulting in the accumulation of the huge amount of H2O2 in the cancer cell. These ROS further causes mitochondrial disruption, protein oxidation, and denaturation of DNA that results in apoptosis of cancer cell. CNPs showing antioxidant effect in normal cell (having physiological pH) by entering into the cell through endocytosis and scavenging ROS (O2·−or H2O2 or ·OH) due to [1] SOD mimetic activity in which superoxide is reduced into H2O2 and [2] CAT mimetic activity in which H2O2 gets further degraded into water, hence protecting the normal cell
Antioxidant activity
| S. no | Particle size/morphology | Cell type | Observation | References |
|---|---|---|---|---|
| 1. | 3–5 nm | Adult rat spinal cord cells | A significant neuroprotective effect on adult rat spinal cord neurons were observed | [ |
| 2. | 4 nm | Cardiomyocytes and human dermal fibroblasts | Dextran-coated nanoceria protects healthy cells against hydrogen peroxide-induced oxidative stress | [ |
| 3. | 3–5 nm | Human colon cells (CRL 1541) | Nanoceria reduce ROS levels and protect healthy human colon cells from radiation-induced damage | [ |
| 4. | 5–8 nm | Cardiac progenitor cells (CPCs) | Nanoceria controls the oxidative stress in CPCs | [ |
| 5. | 20 nm/cubic | Endothelial cells | CeO2 reduces intracellular free radicals in endothelial cells and thus helps in controlling cardiovascular diseases | [ |
| 6. | 5–80 nm/cubic | Neuron-like PC12 cells | CeO2 scavenged ROS and exerted neuroprotection via regulating genes involved in cellular defense | [ |
| 7. | < 25 nm/cubic and triangular | A human epithelial lung cell line, BEAS-2B | Pre-treatment of CeO2 significantly reduced the intracellular production of ROS induced by KBrO3 | [ |
| 8. | 5 nm/spherical | NIH3T3 cells | Levan coated CeO2 protected NIH3T3 cells against H2O2-induced oxidative stress | [ |
| 9. | < 5 nm | Neuron-like SH-SY5Y cells | Showing beneficial effects in terms of neurite development and alignment | [ |
| 10. | 30 nm | Brain tissue samples of rats | CeO2 protected against Paraquat-induced neuronal oxidative stress and apoptosis | [ |
Anticancer activity
| S. no | Size (nm) | Cell line | Observation | References |
|---|---|---|---|---|
| 1. | 20 | Human lung cancer cells (A549 cells) | Free radicals were generated on the exposure of 3.5 to 23.3 µg/mL nanoceria which causes oxidative stress and cytotoxic effect in the cancer cells | [ |
| 2. | 100–200 | Human prostate cancer cell line (PC-3) | Nanoceria showed cytotoxicity in prostate cancer cells but was non-toxic in normal cells at the conc. of 5 mg/mL | [ |
| 3. | 3–5 | Ovarian cancer cells (A2780) and A2780 xenograft murine model | Conc. between 25 and 50 µM showed an anti-angiogenic effect in ovarian cancer cells and reduced tumor size in vivo | [ |
| 4. | 3–5 | Human colon cancer cells (HCT 15) | Conc. between 10 and 100 µM resulted in a significant reduction of cell viability via increasing ROS levels | [ |
| 5. | < 25 | Human neuroblastoma cell line (IMR32) | Nanoceria exposure generated ROS that induced oxidative stress, which leads to cytotoxicity and genotoxicity in IMR32 cells at higher conc. (> 100 µg/mL) | [ |
| 6. | 10 | Ovarian cancer cells (A2780) and A2780 xenograft murine model | Folic acid tagged nanoceria showed significant inhibition in viable cells in A2780 cells within the conc. range 10–100 μM, and reduced tumor size in vivo | [ |
| 7. | 30 | Fibrosarcoma cell line (WEHI164) | Conc. of nanoceria ≥ 15.63 µg/mL showed toxicity effects in cancer cells via increasing ROS levels and apoptosis | [ |
Fig. 5Schematic diagram of drug delivery activity of nanoceria in the cancer cell. Drug @ CNP coated with specific targeting agent is up taken by the cell through endocytosis. Due to low pH and high GSH in endosome, and lysosome drug is released into the cytoplasm and then enter either into nucleus directly and bind with DNA that causes its denaturation or in mitochondria which increased the production of ROS that further attack the nucleus and causes denaturation of DNA, which ultimately lead to cell death
Drug delivery
| S. no | Name of drug | Cell type | Observation | References |
|---|---|---|---|---|
| 1. | Carboxybenzene sulphonamide | None | Showed an inhibition of hCAII which is very useful in the treatment of glaucoma | [ |
| 2. | Camptothecin | Human pancreatic cancer cell lines BxPC-3 cells | Increase in the conc. of camptothecin-loaded nanoceria decreases the cell viability of BxPC-3 cells | [ |
| 3. | Chlorin e6 | Human breast cancer cells (MCF-7/ADR) and MCF-7/ADR xenograft murine model | Showed photodynamic therapy in drug-resistant breast cancer cells and tumor in vivo | [ |
| 4. | Doxorubicin | Human Ovarian cancer cell lines A2780, SKOV-3, and CAOV-3 | Higher cell proliferation inhibition and apoptosis compared with free DOX | [ |
| 5. | Doxorubicin and Hsp90 inhibitor ganetespib (GT) | A549 cells | Co-delivery of Dox and GT using Nanoceria showed more than 80% of NSCLC death within 48 h of incubation | [ |
| 6. | Curcumin | Neuroblastoma cell lines: IMR-32, SMS-KAN, SK-N-AS, and LA–N-6 | Induce substantial cell death in neuroblastoma cells | [ |
| 7. | Doxorubicin | Human liver cancer cells (HepG2 cells) | Showed a synergistic anticancer effect on cancer cells | [ |
Gene delivery
| S. no | Name of gene | Cell type | Observation | References |
|---|---|---|---|---|
| 1. | Luc gene, EGFP gene, and RFP gene | HEK293, MCF-7 and Hep G2 cells | CeO2/DODAB nanovectors could transfect genes in vitro and in vivo without causing any toxic effect | [ |
Fig. 6Schematic representation of gene delivery activity of CNPs. Intracellular uptake of gene functionalized CNPs through endocytosis form endosome from which gene (DNA) is released into the cytosol, and then enter into the nucleus which forms mRNA by transcription and mRNA further form protein by translation
Fig. 7Anti-diabetic activity of nanoceria
Anti-diabetic Effect
| S. no. | Particle size | Model | Observation | References |
|---|---|---|---|---|
| 1. | 180 ± 15.54 nm by DLS and 90 ± 9.5 nm by SEM | STZ-treated diabetic mice were treated with CNPs (0.2 and 2 mg/kg bw, i.p., 28 days) | CNPs treatment decreased the glucose levels, lipid peroxidation, secretion of pro-inflammatory cytokines, and NF-κB protein expression and increased the insulin levels and glutathione concentrations | [ |
| 2. | – | HepG2 cells were treated with 50 mM CNPs against high glucose (50 mM) exposure | Treatment with CNPs significantly decreased the high glucose-induced cytotoxicity, ROS formation, lipid peroxidation, and increased intracellular glutathione | [ |
| 3. | – | STZ-treated diabetic animals were administered CNPs (30 mg/kg bw, daily, i.p., 2 weeks) | CNPs administration alleviated the plasma glucose levels and the deleterious effects of diabetes on the sperm potential fertility, sperm parameters, DNA integrity, and Nrf2 expression levels | [ |
| 4. | – | STZ-treated diabetic animals were administered CNPs (30 mg/kg bw, daily, i.p., 2 weeks) | CNPs administration increased the total antioxidant capacity via upregulating Nrf2 mediated increase in the mRNA expressions of antioxidant genes, namely GCLC, HQ-1, and NQO1 | [ |
| 5. | – | STZ-treated diabetic mice were treated with CNPs (60 mg/kg bw, 16 days) | CNPs treatment significantly prevented embryonic oxidative stress and pathologic changes in diabetic mice | [ |
| 6. | – | Isolated pancreatic islets were pre-treated with CNPs (10, 100, 1000 nM) | Treatment with CNPs increased the cell viability, secretion of insulin, and ATP/ADP ratio and reduced the ROS level | [ |
| 7. | – | Isolated pancreatic islets were pre-treated with CNPs (200 µM) against H2O2 (50 µM, 2 h) | Pre-treatment with CNPs attenuated the ROS formation, caspase-3 activity, and apoptotic cell death and increased cell viability, glucose-induced ATP production, and glucose-stimulated insulin secretion | [ |
Tissue regeneration activity
| S. no | Therapeutic target tissue | Cell type | Observation | References |
|---|---|---|---|---|
| 1. | Bone | Human mesenchymal stem cells (HMSCs) | Bioactive scaffolds containing nanoceria increased the production of collagen and enhanced the osteoblastic differentiation of HMSCs | [ |
| 2. | Bone and soft tissue | Bone marrow stromal cells (BMSCs) | Nanoceria increased the viability of BMSCs and also showed concentration and time-dependent proliferation, osteogenic, and adipogenic differentiation of BMSCs | [ |
| 3. | Nerve | Neuron-like SH-SY5Y cells | Gelatin/nanoceria nanocomposite fibers improved the growth and differentiation of neuronal cells | [ |